TMO — Thermo Fisher Scientific Inc.
$700.22
+$0.78 (+0.11%)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services.
Market Cap
$259.44B
Forward P/E
25.2x
52-Week Range
N/A
TMO Price History
Revenue vs. Net Income
$44.6B
Revenue · FY2025
Annual. Net margin is shown under each year.
Free Cash Flow
$6.3B
FCF · FY2025
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
9.2%
ROCE · FY2025
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
1.9x
Assets ÷ liabilities · FY2025
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
3.4%
CapEx · FY2025
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
-1.3%
Net buyback · FY2025
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
